Position in PFE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,739,064
-$44,953 QoQ
Shares Held
196,805
+15.5% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
1.39%
of 13F equity value
Holder Rank
#620
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Hollow Brook Wealth Management LLC holds $18,211,815 across 8 Drug Manufacturers - General names. PFE ranks #2 (26.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
41,158 | $10,452,897 | |
| 2 | PFE |
Pfizer Inc
This page
|
196,805 | $4,739,064 | |
| 3 | ABBV |
AbbVie Inc.
|
2,525 | $635,391 | |
| 4 | NVS |
Novartis AG
|
3,788 | $593,655 | |
| 5 | MRK |
Merck & Co., Inc.
|
4,113 | $528,520 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
3,546 | $448,001 | |
| 7 | AMGN |
Amgen Inc
|
1,202 | $435,268 | |
| 8 | LLY |
ELI LILLY & Co
|
316 | $379,019 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,739,064 | 196,805 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $4,784,017 | 170,371 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $4,336,384 | 174,152 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $3,571,047 | 140,151 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $3,208,260 | 132,354 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $3,401,818 | 134,247 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $3,716,746 | 140,096 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $1,927,461 | 66,602 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,775,750 | 63,465 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,656,369 | 59,689 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,679,205 | 58,326 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $1,502,103 | 45,285 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $296,007 | 8,070 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $337,008 | 8,260 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $423,242 | 8,260 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $424,472 | 9,700 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $509,776 | 9,723 | Shares | Sole | 2022-07-26 | |
| 2022-03-31 | $729,905 | 14,099 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $832,545 | 14,099 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $507,862 | 11,808 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $462,401 | 11,808 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $427,803 | 11,808 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $447,315 | 12,152 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $487,632 | 13,287 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $395,376 | 12,091 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $394,649 | 12,091 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||